Viropharma Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2013 to a ratio of 7.34, this is below the company average, and notable indication of worsening business environment. Average collection period, for Viropharma Inc's accounts receivable remained unchanged at 50 days, in the Sep 30 2013 quarter.

If we take a look into Healthcare sector 49 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 898, from overall ranking in the second quarter 2013 at 962.

What is Receivable Turnover Ratio?
What is Viropharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VPHM Receivables Turnover Ratio	(Sep 30 2013) III. Quarter	(Jun 30 2013) II. Quarter	(Mar 31 2013) I. Quarter	(Dec 31 2012) IV. Quarter	(Sep 30 2012) III. Quarter
Y / Y Receivable Change	20.42 %	2.44 %	-7.9 %	-5.27 %	-26.4 %
Y / Y Revenue Change	24.24 %	9.59 %	-	-	-
Receivable Turnover Ratio (TTM)	7.34	7.29	7.18	7.03	3
VPHM's Total Ranking	# 898	# 962	# 0	# 0	#
Accounts Receivable average collection period days	50	50	51	52	122
Seq. Receivable Change	9.89 %	-4.17 %	-21.52 %	45.71 %	-6.51 %
Seq. Revenue Change	9.02 %	-	-	166.24 %	-3.84 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 8
Healthcare Sector	# 50
Overall Market	# 898

Receivable Turnover Ratio Statistics
High	Average	Low
9.06	8.33	6.93
(Sep 30 2013)		(Jun 30 2012)

VPHM Company Profile • Back to VPHM Efficiency Comparisons • Compare VPHM Receivables Turnover Ratio to its Competitors

Financial Statements
Viropharma Inc's Accounts Receivable	$ 61 Millions	Visit VPHM's Balance sheet
Viropharma Inc's Sales TTM	$ 459 Millions	Visit VPHM's Income Statement
Sources of VPHM's Revenues		Visit VPHM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VPHM's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VPHM's Growth Rates	VPHM's Roa	VPHM's Inventory Turnover Ratio	VPHM's Dividend Comparisons
VPHM's Profitability Ratios	VPHM's Roi	VPHM's Asset Turnover Ratio	VPHM's Dividend Growth
VPHM's Valuation Ratios	VPHM's Roe	VPHM's Financial Strength Ratios	VPHM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2013, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2013	Receivable at quarter ending Sep 30 2013
Sunlink Health Systems Inc	20.45	$ 110.910 Millions	$ 5.423 Millions
Cytosorbents Corporation	20.09	$ 2.231 Millions	$ 0.111 Millions
Assertio Holdings inc	20.09	$ 120.187 Millions	$ 5.984 Millions
Achari Ventures Holdings Corp I	18.73	$ 122.833 Millions	$ 6.557 Millions
Cytosorbents Corp	18.17	$ 0.881 Millions	$ 0.048 Millions
Ironwood Pharmaceuticals inc	18.08	$ 44.830 Millions	$ 2.480 Millions
Oragenics Inc	17.59	$ 1.028 Millions	$ 0.058 Millions
Wearable Health Solutions, Inc.	17.59	$ 0.693 Millions	$ 0.039 Millions
Cyteir Therapeutics Inc	16.43	$ 1,925.800 Millions	$ 117.200 Millions
Curis Inc	16.43	$ 15.164 Millions	$ 0.923 Millions
Agenus Inc	16.28	$ 3.743 Millions	$ 0.230 Millions
Adma Biologics Inc	16.05	$ 3.762 Millions	$ 0.234 Millions
Chemed Corporation	15.21	$ 1,433.302 Millions	$ 94.256 Millions
International Stem Cell Corporation	15.00	$ 5.659 Millions	$ 0.377 Millions
Arena Pharmaceuticals Inc	14.98	$ 76.814 Millions	$ 5.129 Millions
Aethlon Medical Inc	13.55	$ 1.454 Millions	$ 0.107 Millions
Aspira Women s Health inc	13.21	$ 2.123 Millions	$ 0.161 Millions
Acorda Therapeutics Inc	12.80	$ 325.310 Millions	$ 25.417 Millions
Guided Therapeutics Inc	12.74	$ 1.487 Millions	$ 0.117 Millions
Ligand Pharmaceuticals Incorporated	12.42	$ 47.871 Millions	$ 3.854 Millions
American Caresource Holdings, Inc.	12.38	$ 29.641 Millions	$ 2.394 Millions
Soligenix inc	12.04	$ 4.058 Millions	$ 0.337 Millions
Community Health Systems Inc	12.03	$ 26,322.962 Millions	$ 2,188.565 Millions
Avid Bioservices Inc	11.89	$ 23.335 Millions	$ 1.963 Millions
Statera Biopharma Inc fka Cytocom Inc	11.81	$ 6.778 Millions	$ 0.574 Millions
China Biologic Products Holdings Inc	11.80	$ 194.760 Millions	$ 16.501 Millions
Rockwell Medical inc	11.62	$ 51.415 Millions	$ 4.423 Millions
Surmodics Inc	11.58	$ 56.132 Millions	$ 4.849 Millions
Musclepharm Corporation	11.42	$ 89.877 Millions	$ 7.869 Millions
Interpace Biosciences Inc	11.20	$ 150.060 Millions	$ 13.395 Millions

Date modified: 2026-06-22T16:30:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.